ARISE and COVID-19: Our continued response

ARISE and COVID-19: Our continued response

In response to the current pandemic, the ARISE team have highlighted the impact COVID-19 has on patients living with Sickle Cell. Our recently published ARISE COVID newsletter, summarises all of our activities related to the COVID-19, including recently published...
Novartis’ Expert Advice on Sickle Cell Disease

Novartis’ Expert Advice on Sickle Cell Disease

Staying healthy can be particularly challenging for patients suffering from Sickle Cell Disease (SCD). Novartis in collaboration with medical experts from Europe, Brazil and Middle East developed an expert advice video to support patients with SCD across the...
Paediatric to adult transition care for SCD patients

Paediatric to adult transition care for SCD patients

Within the ARISE project the review “Paediatric to adult transition care for patients with sickle cell disease: a global perspective” was published on the Lancet Haematology journal.   It was written by a task force of experts on transition in sickle cell disease from...